Brain-to-image decoding has been recently propelled by the progress in generative AI models and the availability of large ultra-high field functional Magnetic Resonance Imaging (fMRI). However, current approaches depend on complicated multi-stage pipelines and preprocessing steps that typically collapse the temporal dimension of brain recordings, thereby limiting time-resolved brain decoders. Here, we introduce Dynadiff (Dynamic Neural Activity Diffusion for Image Reconstruction), a new single-stage diffusion model designed for reconstructing images from dynamically evolving fMRI recordings. Our approach offers three main contributions. First, Dynadiff simplifies training as compared to existing approaches. Second, our model outperforms state-of-the-art models on time-resolved fMRI signals, especially on high-level semantic image reconstruction metrics, while remaining competitive on preprocessed fMRI data that collapse time. Third, this approach allows a precise characterization of the evolution of image representations in brain activity. Overall, this work lays the foundation for time-resolved brain-to-image decoding.

In cone beam computed tomography(CBCT)-guided adaptive radiotherapy, rapid and precise segmentation of organs-at-risk(OARs)is essential for accurate dose verification and online replanning. The quality of CBCT images obtained with current onboard CBCT imagers and clinical imaging protocols, however, is often compromised by artifacts such as scatter and motion, particularly for thoracic CBCTs. These artifacts not only degrade image contrast but also obscure anatomical boundaries, making accurate segmentation on CBCT images significantly more challenging compared to planning CT images. To address these persistent challenges, we propose a novel multi-channel conditional consistency diffusion model(MCCDM)for segmentation of OARs in thoracic CBCT images (CBCT-MCCDM), which harnesses its domain transfer capabilities to improve segmentation accuracy across different imaging modalities. By jointly training the MCCDM with CT images and their corresponding masks, our framework enables an end-to-end mapping learning process that generates accurate segmentation of OARs.
This CBCT-MCCDM was used to delineate esophagus, heart, the left and right lungs, and spinal cord on CBCT images from each patient with lung cancer. We quantitatively evaluated our approach by comparing model-generated contours with ground truth contours from 33 patients with lung cancer treated with 5-fraction stereotactic body radiation therapy (SBRT), demonstrating its potential to enhance segmentation accuracy despite the presence of challenging CBCT artifacts. The proposed method was evaluated using average Dice similarity coefficients (DSC), sensitivity, specificity, 95th Percentile Hausdorff Distance (HD95), and mean surface distance (MSD) for each of the five OARs. The method achieved average DSC values of 0.82, 0.88, 0.95, 0.96, and 0.96 for the esophagus, heart, left lung, right lung, and spinal cord, respectively. Sensitivity values were 0.813, 0.922, 0.956, 0.958, and 0.929, respectively, while specificity values were 0.991, 0.994, 0.996, 0.996, and 0.995, respectively. We compared the proposed method with two state-of-art methods, CBCT-only method and U-Net, and demonstrated that the proposed CBCT-MCCDM.

This study explores the use of Federated Learning (FL) for tuberculosis (TB) diagnosis using chest X-rays in low-resource settings across Africa. FL allows hospitals to collaboratively train AI models without sharing raw patient data, addressing privacy concerns and data scarcity that hinder traditional centralized models. The research involved hospitals and research centers in eight African countries. Most sites used local datasets, while Ghana and The Gambia used public ones. The study compared locally trained models with a federated model built across all institutions to evaluate FL's real-world feasibility. Despite its promise, implementing FL in sub-Saharan Africa faces challenges such as poor infrastructure, unreliable internet, limited digital literacy, and weak AI regulations. Some institutions were also reluctant to share model updates due to data control concerns. In conclusion, FL shows strong potential for enabling AI-driven healthcare in underserved regions, but broader adoption will require improvements in infrastructure, education, and regulatory support.

We aimed to prospectively investigate whether bladder volume measured using deep learning artificial intelligence (AI) algorithms (AI-BV) is more accurate than that measured using conventional methods (C-BV) if using a portable ultrasound bladder scanner (PUBS). Patients who underwent filling cystometry because of lower urinary tract symptoms between January 2021 and July 2022 were enrolled. Every time the bladder was filled serially with normal saline from 0 mL to maximum cystometric capacity in 50 mL increments, C-BV was measured using PUBS. Ultrasound images obtained during this process were manually annotated to define the bladder contour, which was used to build a deep learning AI model. The true bladder volume (T-BV) for each bladder volume range was compared with C-BV and AI-BV for analysis. We enrolled 250 patients (213 men and 37 women), and a deep learning AI model was established using 1912 bladder images. There was a significant difference between C-BV (205.5 ± 170.8 mL) and T-BV (190.5 ± 165.7 mL) (p = 0.001), but no significant difference between AI-BV (197.0 ± 161.1 mL) and T-BV (190.5 ± 165.7 mL) (p = 0.081). In bladder volume ranges of 101-150, 151-200, and 201-300 mL, there were significant differences in the percentage of volume differences between [C-BV and T-BV] and [AI-BV and T-BV] (p < 0.05), but no significant difference if converted to absolute values (p > 0.05). C-BV (R² = 0.91, p < 0.001) and AI-BV (R² = 0.90, p < 0.001) were highly correlated with T-BV. The mean difference between AI-BV and T-BV (6.5 ± 50.4) was significantly smaller than that between C-BV and T-BV (15.0 ± 50.9) (p = 0.001). Following image pre-processing, deep learning AI-BV more accurately estimated true BV than conventional methods in this selected cohort on internal validation. Determination of the clinical relevance of these findings and performance in external cohorts requires further study. The clinical trial was conducted using an approved product for its approved indication, so approval from the Ministry of Food and Drug Safety (MFDS) was not required. Therefore, there is no clinical trial registration number.

Accurately registering breast MR images from different time points enables the alignment of anatomical structures and tracking of tumor progression, supporting more effective breast cancer detection, diagnosis, and treatment planning. However, the complexity of dense tissue and its highly non-rigid nature pose challenges for conventional registration methods, which primarily focus on aligning general structures while overlooking intricate internal details. To address this, we propose \textbf{GuidedMorph}, a novel two-stage registration framework designed to better align dense tissue. In addition to a single-scale network for global structure alignment, we introduce a framework that utilizes dense tissue information to track breast movement. The learned transformation fields are fused by introducing the Dual Spatial Transformer Network (DSTN), improving overall alignment accuracy. A novel warping method based on the Euclidean distance transform (EDT) is also proposed to accurately warp the registered dense tissue and breast masks, preserving fine structural details during deformation. The framework supports paradigms that require external segmentation models and with image data only. It also operates effectively with the VoxelMorph and TransMorph backbones, offering a versatile solution for breast registration. We validate our method on ISPY2 and internal dataset, demonstrating superior performance in dense tissue, overall breast alignment, and breast structural similarity index measure (SSIM), with notable improvements by over 13.01% in dense tissue Dice, 3.13% in breast Dice, and 1.21% in breast SSIM compared to the best learning-based baseline.

This retrospective study evaluates the diagnostic performance of an optimized comprehensive multi-stage framework based on the Segment Anything Model (SAM), which we named Dr-SAM, for detecting and grading vascular stenosis in the abdominal aorta and iliac arteries using digital subtraction angiography (DSA). A total of 100 DSA examinations were conducted on 100 patients. The infrarenal abdominal aorta (AAI), common iliac arteries (CIA), and external iliac arteries (EIA) were independently evaluated by two experienced radiologists using a standardized 5-point grading scale. Dr-SAM analyzed the same DSA images, and its assessments were compared with the average stenosis grading provided by the radiologists. Diagnostic accuracy was evaluated using Cohen's kappa, specificity, sensitivity, and Wilcoxon signed-rank tests. Interobserver agreement between radiologists, which established the reference standard, was strong (Cohen's kappa: CIA right = 0.95, CIA left = 0.94, EIA right = 0.98, EIA left = 0.98, AAI = 0.79). Dr-SAM showed high agreement with radiologist consensus for CIA (κ = 0.93 right, 0.91 left), moderate agreement for EIA (κ = 0.79 right, 0.76 left), and fair agreement for AAI (κ = 0.70). Dr-SAM demonstrated excellent specificity (up to 1.0) and robust sensitivity (0.67-0.83). Wilcoxon tests revealed no significant differences between Dr-SAM and radiologist grading (p > 0.05). Dr-SAM proved to be an accurate and efficient tool for vascular assessment, with the potential to streamline diagnostic workflows and reduce variability in stenosis grading. Its ability to deliver rapid and consistent evaluations may contribute to earlier detection of disease and the optimization of treatment strategies. Further studies are needed to confirm these findings in prospective settings and to enhance its capabilities, particularly in the detection of occlusions.

AimsAortic stenosis (AS) is a progressive disease requiring timely monitoring and intervention. While transthoracic echocardiography (TTE) remains the diagnostic standard, deep learning (DL)-based approaches offer potential for improved disease tracking. This study examined the longitudinal changes in a previously developed DL-derived index for AS continuum (DLi-ASc) and assessed its value in predicting progression to severe AS. Methods and ResultsWe retrospectively analysed 2,373 patients a(7,371 TTEs) from two tertiary hospitals. DLi-ASc (scaled 0-100), derived from parasternal long- and/or short-axis views, was tracked longitudinally. DLi-ASc increased in parallel with worsening AS stages (p for trend <0.001) and showed strong correlations with AV maximal velocity (Vmax) (Pearson correlation coefficients [PCC] = 0.69, p<0.001) and mean pressure gradient (mPG) (PCC = 0.66, p<0.001). Higher baseline DLi-ASc was associated with a faster AS progression rate (p for trend <0.001). Additionally, the annualised change in DLi-ASc, estimated using linear mixed-effect models, correlated strongly with the annualised progression of AV Vmax (PCC = 0.71, p<0.001) and mPG (PCC = 0.68, p<0.001). In Fine-Gray competing risk models, baseline DLi-ASc independently predicted progression to severe AS, even after adjustment for AV Vmax or mPG (hazard ratio per 10-point increase = 2.38 and 2.80, respectively) ConclusionDLi-ASc increased in parallel with AS progression and independently predicted severe AS progression. These findings support its role as a non-invasive imaging-based digital marker for longitudinal AS monitoring and risk stratification.

Low-dose CT (LDCT) images are often accompanied by significant noise, which negatively impacts image quality and subsequent diagnostic accuracy. To address the challenges of multi-scale feature fusion and diverse noise distribution patterns in LDCT denoising, this paper introduces an innovative model, CTLformer, which combines convolutional structures with transformer architecture. Two key innovations are proposed: a multi-scale attention mechanism and a dynamic attention control mechanism. The multi-scale attention mechanism, implemented through the Token2Token mechanism and self-attention interaction modules, effectively captures both fine details and global structures at different scales, enhancing relevant features and suppressing noise. The dynamic attention control mechanism adapts the attention distribution based on the noise characteristics of the input image, focusing on high-noise regions while preserving details in low-noise areas, thereby enhancing robustness and improving denoising performance. Furthermore, CTLformer integrates convolutional layers for efficient feature extraction and uses overlapping inference to mitigate boundary artifacts, further strengthening its denoising capability. Experimental results on the 2016 National Institutes of Health AAPM Mayo Clinic LDCT Challenge dataset demonstrate that CTLformer significantly outperforms existing methods in both denoising performance and model efficiency, greatly improving the quality of LDCT images. The proposed CTLformer not only provides an efficient solution for LDCT denoising but also shows broad potential in medical image analysis, especially for clinical applications dealing with complex noise patterns.

The rapid advancement of Large Language Models (LLMs) has stimulated interest in multi-agent collaboration for addressing complex medical tasks. However, the practical advantages of multi-agent collaboration approaches remain insufficiently understood. Existing evaluations often lack generalizability, failing to cover diverse tasks reflective of real-world clinical practice, and frequently omit rigorous comparisons against both single-LLM-based and established conventional methods. To address this critical gap, we introduce MedAgentBoard, a comprehensive benchmark for the systematic evaluation of multi-agent collaboration, single-LLM, and conventional approaches. MedAgentBoard encompasses four diverse medical task categories: (1) medical (visual) question answering, (2) lay summary generation, (3) structured Electronic Health Record (EHR) predictive modeling, and (4) clinical workflow automation, across text, medical images, and structured EHR data. Our extensive experiments reveal a nuanced landscape: while multi-agent collaboration demonstrates benefits in specific scenarios, such as enhancing task completeness in clinical workflow automation, it does not consistently outperform advanced single LLMs (e.g., in textual medical QA) or, critically, specialized conventional methods that generally maintain better performance in tasks like medical VQA and EHR-based prediction. MedAgentBoard offers a vital resource and actionable insights, emphasizing the necessity of a task-specific, evidence-based approach to selecting and developing AI solutions in medicine. It underscores that the inherent complexity and overhead of multi-agent collaboration must be carefully weighed against tangible performance gains. All code, datasets, detailed prompts, and experimental results are open-sourced at https://medagentboard.netlify.app/.

Combined Pulmonary Fibrosis and Emphysema (CPFE), formally recognized as a distinct pulmonary syndrome in 2022, is characterized by unique clinical features and pathogenesis that may lead to respiratory failure and death. However, the diagnosis of CPFE presents significant challenges that hinder effective treatment. Here, we assembled three-dimensional (3D) reconstruction data of the chest High-Resolution Computed Tomography (HRCT) of patients from multiple hospitals across different provinces in China, including Xiangya Hospital, West China Hospital, and Fujian Provincial Hospital. Using this dataset, we developed CPFENet, a deep learning-based diagnostic model for CPFE. It accurately differentiates CPFE from COPD, with performance comparable to that of professional radiologists. Additionally, we developed a CPFE score based on radiomic analysis of 3D CT images to quantify disease characteristics. Notably, female patients demonstrated significantly higher CPFE scores than males, suggesting potential sex-specific differences in CPFE. Overall, our study establishes the first diagnostic framework for CPFE, providing a diagnostic model and clinical indicators that enable accurate classification and characterization of the syndrome.